Table 2. Drug Susceptibility Testing (DST) Methods Employed in Publications.
| Upper Limit Drug Concentration used to determine resistance (µl/ml) | |||||
| PubMed ID | DST Method | AMK | KAN | CAP | DST Conforms to Published Standard |
| 19386845 | MGIT 960 | 1.0 | ND | 2.5 | Yes [73] |
| 19470506 | MGIT 960 | 1.0 | ND | 2.5 | Yes [73] |
| 20713679 | MGIT 960 | 1.0 | 4.0 | 2.5 | Yes [73] |
| 21732736 | MGIT 960 | 1.0 | ND | 2.5 | Yes [73] |
| 20028780 | BACTEC 460 | 1.0 | 5.0 | 1.25 | Yes [6] |
| 20335420 | Lowenstein-Jensen | 20* | 20 | 20* | Yes* [74] |
| 20573868 | Lowenstein-Jensen | ND | 20 | ND | Yes [74] |
| 20854453 | Lowenstein-Jensen | ND | 30 | 40 | Yes [75] |
| 19634718 | Lowenstein-Jensen | 20* | 20 | ND | Yes* [74] |
| 19752274 | Lowenstein-Jensen | 40 | 30 | 40 | Yes [73] |
| 09593173 | Lowenstein-Jensen | “standard” | “standard” | ND | Yes [75] |
| 19890396 | Lowenstein-Jensen | ND | 20 | ND | Yes [74] |
| 12937004 | Middlebrook 7H10 | 4.0 | 4.0 | ND | Yes [6], [76] |
| 20032248 | Middlebrook 7H10 | 4.0 | 5.0 | 10 | Yes [6], [73], [76] |
| 15673735 | Middlebrook 7H10 | 4.0 | 5.0 | 10 | Yes [6], [73], [76] |
| 16048924 | Middlebrook 7H10 | 4.0 | 5.0 | 10 | Yes [6], [73], [76] |
| 19906990 | Middlebrook 7H10 | 4.0 | 5.0 | ND | Yes [6], [73], [76] |
| 21300839 | Middlebrook 7H10 | 4.0 | 5.0 | 10 | Yes [6], [73], [76] |
| 21427106 | Middlebrook 7H10 | 1.0 | 4.0 | 8.0 | Yes [77] |
| 20185419 | Middlebrook 7H11 | ND | 6.0 | ND | Yes [73] |
| 21562102 | Middlebrook 7H11 | 6.0* | 6.0 | 10 | Yes* [73] |
| 09574680 | Ogawa Egg Medium | ND | ND | 100 | Yes [78] |
*
No publication found to validate DST concentration.
AMK = amikacin, KAN = kanamycin, CAP = capreomycin.
ND = not done.